Status:
TERMINATED
Dietary Intervention for Cardiovascular Disease
Lead Sponsor:
Academia Sinica, Taiwan
Collaborating Sponsors:
Taipei Veterans General Hospital, Taiwan
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
45-75 years
Phase:
NA
Brief Summary
Incidence of cardiometabolic disease (CMD) continues to rise, which consumes huge medical resources in Taiwan. The effectiveness of dietary therapy for CMD has not been locally evaluated in detail. CV...
Eligibility Criteria
Inclusion
- Have received percutaneous transluminal coronary artery surgery.
- Stable drug control for more than one month
Exclusion
- Suffer from cancer and undergo chemotherapy or surgery within one year.
- Those who have a major illness in hospital within one year.
- Those with kidney disease stage 5 (inclusive) or above
- Those whose life expectancy does not exceed half a year
- Patients with diagnosed dementia
- Those who do not want to be tracked
Key Trial Info
Start Date :
December 23 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 14 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05201898
Start Date
December 23 2021
End Date
February 14 2023
Last Update
October 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Veterans General Hospital
Taipei, Beitou District, Taiwan, 112